Eli Lilly is the company founded in 1876 that makes the diabetes drug Mounjaro.
Colonel Eli Lilly, a pharmaceutical chemist and Union army veteran, established the company in Indianapolis, Indiana, in May 1876. The business grew by emphasizing standardized medicines and later became one of the world’s largest pharmaceutical companies by market value.
Mounjaro is the brand name for tirzepatide, which is approved for treating type 2 diabetes in several markets. Tirzepatide acts on GIP and GLP-1 pathways. The same active ingredient is marketed as Zepbound in the United States for chronic weight management under specified conditions.
Mounjaro is often confused with Novo Nordisk’s Ozempic and Wegovy, which contain semaglutide. Eli Lilly’s portfolio also includes insulin products, antidepressants, and treatments for cancer and immune disorders.